EUCAST 2012 Definitions Interpretations

Post on 08-Feb-2016

60 views 0 download

Tags:

description

EUCAST AST guidelines 2012

transcript

EUCAST definitions(and breakpoint table, MIC and

zone distribution website conventions)

Derek BrownECCMID 2011, Milan

Clinically susceptible/resistant

• A microorganism is defined as susceptible by a level of antimicrobial activity associated with a high likelihood of therapeutic success

• A microorganism is defined as resistant by a level of antimicrobial activity associated with a high likelihood of therapeutic failure.

Clinically intermediateA microorganism is defined as intermediate by a level of antimicrobial activity associated with uncertain therapeutic effect.

• It implies that an infection due to the isolate may be appropriately treated in body sites where the drugs are physically concentrated or when a high dosage of drug can be used

• (In susceptibility testing it also indicates a buffer zone that should prevent small, uncontrolled, technical variation from causing major discrepancies in interpretation)

Clinical breakpoints

• a microorganism is categorized as susceptible (S), intermediate (I) or resistant (R) by applying the appropriate breakpoint in a defined phenotypic test system

• MICs are the primary breakpoints• Breakpoints in other methods are correlated

with MIC breakpoints

Breakpoints and cut-off values

• Clinical breakpoints

• Non-species-related breakpoints

• Epidemiological cut-off value (ECOFF)

Non-species-related breakpoints

• Pk/Pd (pharmacokinetic/pharmacodynamic) breakpoints

• Used in clinical breakpoint development

• Can be a guide to interpretation in situations where there is no species-specific clinical breakpoint

Epidemiological cut-off value (ECOFF)

• MIC value identifying the upper limit of the wild type population

• A microorganism is defined as wild type (WT) for a species by the absence of acquired and mutational mechanisms of resistance to the agent.

EUCAST wild type and ECOFF

Wild type

ECOFF

EUCAST wild type and ECOFF

ECOFF

Wild type

Epidemiological cut-off values (ECOFFs)

• Estimated by visual inspection or statistically calculated (Turnidge et al CMI 2006;12:418-25)

• The ECOFF is not changed by sampling time, source (human, animal, environmental), geographical origin

• Used in clinical breakpoint development and as a sensitive indicator of resistance development in surveillance studies.

Relationship between the clinical breakpoints, non-species-related

breakpoints and ECOFFs• Non-species-related breakpoints will be same as

clinical breakpoints unless they split the wild type or there is no resistance

• There is no definitive relationship between clinical breakpoints and ECOFFs

Clinical breakpoint higher than ECOFF

ECOFF S breakpoint R breakpoint

Non-sp-related BP S R Non-sp-related BP

Clinical breakpoint same as ECOFF

ECOFF

S/I and R breakpoint

Non-sp-related BP S R Non-sp-related BP

Clinical breakpoint lower than ECOFF

ECOFF

S breakpoint R breakpoint

Non-sp-related BP S R Non-sp-related BP

ECOFF and zone diameters

ECOFF

Wild type

EUCAST breakpoint tables v 1.3

Highlight indicates change since last version

EUCAST breakpoint table notes

S ≤ , R >MIC R>4 mg/L ≡ ≥8 mg/LZone R<24mm ≡ ≤ 23 mm

EUCAST breakpoint format

S ≤1, R >4

Susceptible ResistantI

S ≤1, R ≥8

Susceptible ResistantI

12864321684210.5

EUCAST intermediate category

Intermediate category is not displayede.g. Ciprofloxacin S≤0.5 mg/L, R>1 mg/L,Intermediate inferred >0.5-1 mg/L

S ≥ 22 mm, R<18 mm,Intermediate inferred 18-21 mm

“-” Susceptibility testing not recommended as the species is a poor target for therapy with the drug(do not test, or do not report, orreport as R)

EUCAST table abbreviations

“IE” Insufficient evidence to set a breakpoint (report MIC values with comment but no categorical interpretation)

“NA” Not Applicable (used for screening tests when they are not applicable to particular organisms)

EUCAST table abbreviations

“IP” In preparation (breakpoints will be established)

Click on antibiotic for Rationale Document

EUCAST breakpoint table links to rationale documents

Click on MIC breakpoint for MIC distributions

EUCAST breakpoint table links to MIC distributions

Click on zone breakpoint for zone diameter distributions

EUCAST breakpoint table links to zone diameter distributions

EUCAST website (www.EUCAST.org)

EUCAST MIC and zone diameter distributions website

EUCAST MIC and zone distributions

Select MIC or zone diameter distribution

Select agent or species

Blue indicates wild type

Clinical breakpoints and ECOFF

Link to graph

EUCAST MIC and zone distributions

EUCAST MIC distributions

Do not infer resistance rates

May include truncated distributions

EUCAST MIC distributionsInsufficient data to define ECOFF

EUCAST zone diameter distributions

EUCAST MIC-zone diameter correlation

Summary

• EUCAST provides clinical breakpoints, non-species-related breakpoints and epidemiological cut-off values (ECOFF)

• Be aware of formatting conventions and abbreviations in EUCAST breakpoint tables and on EUCAST MIC and zone diameter distributions website

www.EUCAST.org